FDAFDA · Food and drugs·Recall number D-1329-2022
Lamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-367-10, UPC 3 42291 36710 4
Published August 17, 2022 · Recall initiated: July 20, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Error on Declared Strength
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- LAMOTRIGINE
- Manufacturer
- AVKARE Inc.
- Distributor
- Nationwide within the United States
- UPC
- 0342291368606
- Lot
- Lot #: 42581 Exp. 12/2024; 42484 Exp. 11/2024; 41204 Exp. 05/2024; 38723 Exp. 02/2023; 37623 Exp. 10/2022
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.